| SOPA Images/LightRocket via Getty Images Key Takeaways Amgen is buying Horizon Therapeutics for just over $26 billion, or $116.50 per share. Horizon has two major drugs, Tepezza and Krystexxa, a thy...
Tag: Horizon Therapeutics
Why Atlanta Tops the Hottest 2023 Real Estate Markets
Atlanta is hot. Georgia’s capital tops the National Association of Realtors’ list of markets to watch in 2023, based on 10 metrics, including housing affordability, employment conditions, and populati...
Horizon Therapeutics, Coupa Software, Rivian, and More Stock Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...